Boston Scientific Corporation

Boston Scientific Corporation

Boston Scientific Corporation

Overview
Date Founded

1979

Headquarters

300 Boston Scientific Way, Marlborough, MA, 01752, United States

Type of Company

Public

Employees (Worldwide)

38K

Industries

Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Industrial Machinery & Manufacturing
Electrical Products

Company Description

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Contact Data
Trying to get in touch with decision makers at Boston Scientific Corporation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Vice President & Chief Financial Officer

Vice President, Global Controller & Chief Accounting Officer

Senior Vice President & President, EMEA

President, Urology & Pelvic Health Division

Director, New Business Development

Executive Vice President & President, Interventional Cardiology

Executive Vice President, Global Operations

Executive Vice President & President, Peripheral Interventions

Executive Vice President & President, MedSurg & President, Endoscopy

Board of Directors

Chief Executive Officer at Boston Scientific Corporation

Co-Founder at Silver Lake Management Co. LLC

Former President & Chief Executive Officer at Becton, Dickinson & Co.

Former Senator from New Hampshire

Founder at Lardon & Associates LLC

Former Chief Financial Officer, Vice President of Finance & Treasurer at Infrared Industries, Inc.

Assistant Professor in the Department of Medicine, Division of Clinical Care Research at Tufts University - School of Medicine

Founder at Pine Grove Holdings LLC

Director at Toshiba Corp.

Founder at Argosy Foundation

Paths to Boston Scientific Corporation
Potential Connections via
Relationship Science
You
Boston Scientific Corporation
Owners & Shareholders
Details Hidden

WMC relies on their extensive independent research and include portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has a number of different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. Their portfolio management teams often include dedicated analysts who evaluate securities and other instruments for suitability based on the team’s investment approach. WMC supplements their internal research with external research from sources such as broker/dealers and third-party research firms. These sources typically provide data, research and analysis and may serve as a gauge of market consensus.

Details Hidden

MFS Investment Management employs a variety of methods to evaluate securities, including fundamental analysis and quantitative analysis. The firm offers fundamental, active and research-driven equity strategies that strive for less volatility relative to benchmarks and greater value through changing markets. Fixed income strategy offers total return focused and credit-oriented approach. Multi-Asset strategy is goal-oriented, diversified and disciplined investment approach that combines broad diversification across multiple asset classes, active asset allocation, and bottom-up security selection. MFS' retirement solutions are designed with a goal of maximizing growth and supporting income over a lifetime by focusing on long-term returns. MFS Blended Research is an approach to active equity management that combines the firm’s fundamental research expertise with highly systematic quantitative research.

Details Hidden

JCM offers US equity, global & international equity, fixed income, asset allocation and alternative investment strategies, including but not limited to long-short portfolios. For its fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through its own intensive fundamental research. For its equity strategies, JCM favors businesses that its research reveals have sustainable, above-average earnings growth potential and outstanding free cash flow generation, recurring revenue, profit margins and return on invested capital. Their fixed income research focuses on businesses that have strong or improving balance sheets, improving free-cash flow generation and recurring revenue.

Recent Transactions
Details Hidden

Boston Scientific Corporation purchases Lumenis Ltd. from Baring Private Equity Asia Ltd.

Details Hidden

Boston Scientific Corporation purchases Preventice Solutions, Inc. from CR Group LP

Details Hidden

Boston Scientific Corporation issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onBoston Scientific Corporation purchases Guidant Corporation

Accountant

Advised onBoston Scientific Corporation purchases Guidant Corporation

Legal Advisor

Advised onBoston Scientific Corporation purchases VertiFlex, Inc. from Alta Partners Management Corp., Aberdare Ventures, New Enterprise Associates, Inc., Thomas McNerney Ptn, Morgenthaler Management Corp., Endeavour Vision SA, H.I.G. BioHealth Partners LLC

Legal Advisor

Advised onBoston Scientific Corporation purchases Guidant Corporation

Legal Advisor

Advised onBoston Scientific Corporation purchases Asthmatx, Inc.

Legal Advisor

Advised onBoston Scientific Corporation purchases Symetis SA from Kreos Capital Management (UK) Ltd., Wellington Partners GmbH, Novartis Venture Fund, Aravis AG, Stage Capital Ventures, Endeavour Vision SA, Truffle Capital, BioMedPartners AG, Renaissance Management SA

Advisors & Consultants
Legal Advisor

Partner at Arnold & Porter LLP

Legal Advisor

Founding Member at Sandberg Phoenix & von Gontard PC

Legal Advisor

Partner at Proskauer Rose LLP

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Beaumont Health engages in the provision of healthcare services. It offers spine surgery, weight loss, wound treatment, home health services, integrative medicine, and senior services. The company was founded on September 2, 2014 and is headquartered in Royal Oak, MI.

Aamal Co. engages in diversified business sectors, including industrial manufacturing, property, retail, managed services, medical equipment, and pharmaceutical. It operates through the following segments: Industrial Manufacturing, Trading and Distribution, Property, and Managed Services. The Industrial Manufacturing segment manufactures and distributes electric cables and tools, aggregates, ready-mix concrete, and cement blocks. The Trading and Distribution segment offers pharmaceutical and consumable items, home appliances, medical equipment, tires and lubricants, and perfumes and cosmetic items. The Property segment involves in real estate investments and property rental businesses. The Managed Services segment provides housekeeping and cleaning, facilities management, energy, call center, building maintenance, and travel agency services. The company was founded by Faisal bin Qassim Al-Thani on January 13, 2001 and is headquartered in Doha, Qatar.

Key Stats and Financials As of 2020
Market Capitalization
$59.7B
Total Enterprise Value
$58.6B
Earnings Per Share
$-0.08
Revenue
$9.91B
TEVNet Income
-714.66x
Debt TEV
0.16x
Enterprise Value / Sales
5.91x
Net Profit
$-82M
Total Equity
$15.3B
Total Debt
$9.61B
EBITDAMargin
17.38%
Enterprise Value EBITDAOperating
33.74x
EBITDA
$1.72B
Three Year Compounded Annual Growth Rate Of Revenue
3.09%
Non-Profit Donations & Grants
Political Donations
$1,000
2014
$500
2014
$1,000
2014
Investments
Details Hidden

Amaranth Medical, Inc. develops and manufactures a technology platform for fully bioresorbable scaffolds. It operates as a holding company that engages in the development and manufacture of technology platform for fully bioresorbable scaffolds. Its proprietary bioresorbable technology platform holds great potential for both vascular and nonvascular applications. The company was founded by Freddy Yin Chiang Boey and Subbu S. Venkatraman in 2005 and is headquartered in Mountain View, CA.

Details Hidden

InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL.

Details Hidden

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

Investors
Details Hidden

Advisor at Buoy Health, Inc.

Details Hidden

Co-Founder & Board Member at BeneChill, Inc.

Details Hidden

Investor at Moore Medical LLC

Suppliers
Bemis Co., Inc. Paper Products

Bemis Co., Inc. engages in the manufacture and sale of packaging for the food, healthcare, and pharmaceutical companies. It operates through the following segments: U.S. Packaging; Latin America Packaging; Rest of the World Packaging; and Corporate. The U.S. Packaging segment manufactures multilayer polymer, blown and cast film structures which are then converted to produce packaging for processed and fresh meat, dairy, liquids, frozen foods, cereals, snacks, cheese, coffee, condiments, candy, pet food, bakery, lawn and garden, tissue, fresh produce, personal care and hygiene, and agribusiness in the United States. The Latin America Packaging segment focuses in the production of multilayer polymer, blown, and cast film structures to produce packaging sold for a variety of food, medical, pharmaceutical, personal care, electronics, and industrial applications in Latin America. The Rest of World Packaging Segment comprises food and non-food packaging-related manufacturing operations located in Europe and Asia-Pacific as well as medical device and pharmaceutical packaging-related manufacturing operations in the U.S., Europe, and Asia. The company was founded by Judson Moss Bemis in 1858 and is headquartered in Neenah, WI.

SurModics, Inc. Medical Products & Equipment | Eden Prairie, MN

SurModics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

IXYS LLC Semiconductors | Milpitas, CA

IXYS LLC engages in the design, development, manufacture, and marketing of power semiconductors and mixed-signal integrated circuits. It also offers microcontrollers, green energy products, and radio frequency power and systems. The company was founded by Nathan Zommer in 1983 and is headquartered in Milpitas, CA.

Competitors
Medtronic Plc Medical Products & Equipment - Dublin, Irl

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Awards & Honors
Rank #359
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #359
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Boston Scientific Corporation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Boston Scientific Corporation's profile does not indicate a business or promotional relationship of any kind between RelSci and Boston Scientific Corporation.